The decreased abundance of ANXA4 in RELA immunoprecipitate after NF-κB inhibition in our study suggests that ANXA4 interplays with NF-κB also in the breast cancer and could promote metastatic behavior of breast tumors via NF-κB pathway. Here, ANXA4 is linked to breast carcinoma.